Novavax, Inc.NVAXNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank93
3Y CAGR-11.1%
5Y CAGR+118.8%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-11.1%/yr
vs +161.3%/yr prior
5Y CAGR
+118.8%/yr
Recent deceleration
Acceleration
-172.4pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
50.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$1.12B+64.7%
2024$682.16M+22.6%
2023$556.38M-65.2%
2022$1.60B+709.3%
2021$197.58M+782.5%
2020$22.39M+20.0%
2019$18.66M-45.6%
2018$34.29M+10.0%
2017$31.18M+103.1%
2016$15.35M-